Presentation is loading. Please wait.

Presentation is loading. Please wait.

Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro.

Similar presentations


Presentation on theme: "Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro."— Presentation transcript:

1 Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis 
Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro Kamota, MD, Mako Ohshima, PhD, Bungo Shirasawa, MD, PhD, Kimikazu Hamano, MD, PhD  Journal of Vascular Surgery  Volume 52, Issue 2, Pages (August 2010) DOI: /j.jvs Copyright © 2010 Society for Vascular Surgery Terms and Conditions

2 Fig 1 The effect of shock wave (SW) treatment on lymphedema. A, Measurement of ear thickness showed that the SW group had significantly thinner skin than the control group 4 weeks after treatment. *P < .05 vs control group (n = 7/group). Mean data are presented with the standard error of the mean. B, Representative histologic images for the SW-treated and untreated (control) lymphedematous ear 4 weeks after treatment. Bars indicate 1000 μm (upper panels, original magnification ×20) and 100 μm (lower panels, original magnification ×200; hematoxylin and eosin stain). Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Analysis of vascular endothelial growth factor (VEGF)-C expression in skin tissue 4 weeks after shock wave (SW) treatment. A, Representative images of Western blot analysis for VEGF-C. B, Quantification after normalization to β-actin showed that the expression of VEGF-C was significantly higher in the SW group than in the control group. *P < .05 vs control group (n = 4/group). Mean data are presented with the standard error of the mean. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Analysis of vascular endothelial growth factor receptor 3 (VEGFR3) expression in skin tissue 4 weeks after shock wave (SW) treatment. A, Representative images of Western blot analysis for VEGFR3. B, Quantification after normalization to β-actin revealed significantly higher expression of VEGFR3 in the SW group than in the control group. *P < .05 vs control group (n = 4/group). Mean data are presented with the standard error of the mean. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

5 Fig 4 Histologic analysis of the lymphatic vessels in the lymphedematous ear 4 weeks after shock wave (SW) treatment. A, Representative images of immunostaining for vascular endothelial growth factor receptor 3 (VEGFR3; arrows). Bars indicate 50 μm (original magnification ×400). B, Quantification analysis revealed significantly increased density of the lymphatic vessels in the SW group compared with the control group. *P < .05 vs. control group (n = 3/group). Mean data are presented with the standard error of the mean. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions


Download ppt "Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro."

Similar presentations


Ads by Google